| Suraksha Diagnostic Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 544293 |
NSE Symbol : SURAKSHA |
P/E(TTM) : 38.24 |
|
ISIN Demat : INE877V01027 |
Div & Yield% : 0.20 |
EPS(TTM) : 6.54 |
|
Book Value(₹) : 47.96 |
Market Cap(₹Cr) : 1,302.54 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 78.56 | 75.58 | 76.26 | 70.28 | 64.15 | 58.57 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 78.56 | 75.58 | 76.26 | 70.28 | 64.15 | 58.57 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.30 | 0.99 | 0.97 | 1.10 | 0.94 | 0.97 |
| Total Income | 79.86 | 76.57 | 77.23 | 71.37 | 65.09 | 59.54 |
| Total Expenditure | 54.75 | 52.39 | 52.29 | 46.44 | 44.32 | 40.48 |
| PBIDT | 25.11 | 24.18 | 24.94 | 24.93 | 20.76 | 19.07 |
| Interest | 3.87 | 3.10 | 2.72 | 2.66 | 2.06 | 2.03 |
| PBDT | 21.24 | 21.08 | 22.22 | 22.27 | 18.70 | 17.03 |
| Depreciation | 10.69 | 10.11 | 9.65 | 9.15 | 8.66 | 8.62 |
| Tax | 2.39 | 2.39 | 3.08 | 2.86 | 1.46 | 2.15 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.45 | 0.43 | 0.12 | 0.42 | 0.57 | -0.09 |
| Reported Profit After Tax | 6.71 | 8.14 | 9.36 | 9.85 | 8.01 | 6.36 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 6.71 | 8.14 | 9.36 | 9.85 | 8.01 | 6.36 |
| EPS (Unit Curr.) | 1.29 | 1.56 | 1.80 | 1.89 | 1.54 | 1.22 |
| EPS (Adj) (Unit Curr.) | 1.29 | 1.56 | 1.80 | 1.89 | 1.54 | 1.22 |
| Calculated EPS (Unit Curr.) | 1.29 | 1.56 | 1.80 | 1.89 | 1.54 | 1.22 |
| Calculated EPS (Adj) (Unit Curr.) | 1.29 | 1.56 | 1.80 | 1.89 | 1.54 | 1.22 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.15 | 6.25 | 7.19 | 7.56 | 6.15 | 4.88 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.15 | 6.25 | 7.19 | 7.56 | 6.15 | 4.88 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.42 | 10.42 | 10.42 | 10.42 | 10.42 | 10.42 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 31.96 | 31.99 | 32.70 | 35.47 | 32.36 | 32.56 |
| PBDTM(%) | 27.04 | 27.89 | 29.14 | 31.69 | 29.15 | 29.08 |
| PATM(%) | 8.54 | 10.77 | 12.27 | 14.02 | 12.49 | 10.86 |
